Surveys and Interviews to Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program (NCI)

Forms and Documents

Document	Type	Status	Availability
Form 3 Technology End Users Interview Guide	Form and Instruction	New	Available
Form 2 Technology Grantees Web-based Survey	Form and Instruction	New	Available
Form 1 IMAT Grantee Interview	Form and Instruction	New	Available
Attachment 8_Invitation to Participate.docx	Supplementary Document	Uploaded 2015-03-09	Available
Attachment 7_OHSRP_NCI_12656_CY2014.pdf	Supplementary Document	Uploaded 2015-03-09	Available
Attachment 6_Privacy Act Memo.doc	Supplementary Document	Uploaded 2015-03-09	Available
Attachment 5_Evaluation Advisory Committee.doc	Supplementary Document	Uploaded 2015-03-09	Available
Attachment 4_BackgroundRationaleIMAT.doc	Supplementary Document	Uploaded 2015-03-09	Repair queued
SSB IMAT 2-20-2015.docx	Supporting Statement B	Uploaded 2015-03-09	Repair queued
SSA IMAT 02-20-2015.docx	Supporting Statement A	Uploaded 2015-03-09	Repair queued

IC Document Collections

IC ID	Collection	Type	Status	Form
215628	Technology End Users Interview Guide	Form and Instruction	New
215627	Technology Grantees Web-based Survey	Form and Instruction	New
215626	IMAT Grantee Interview	Form and Instruction	New

ICR Details

OMB Control No: 0925-0720	ICR Reference No: 201503-0925-003
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/NIH	Agency Tracking No:
Title: Surveys and Interviews to Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program (NCI)
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 05/29/2015
	Date Received in OIRA: 03/10/2015
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	05/31/2016	12 Months From Approved
Responses	1,050	0	0
Time Burden (Hours)	575	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: This request is to gain OMB approval for the new submission titled, "Surveys and Interviews to Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program" for 1 year. The National Cancer Institute (NCI) IMAT program was launched in 1998 to support the development of highly innovative technologies to advance cancer research and clinical care capabilities. NCI is proposing to pursue a comprehensive and robust evaluation to assess the process and outcomes of the IMAT program, and also seek opportunities for NCI to improve the program's utility for the broad continuum of cancer researchers, clinicians and ultimately patients. The focus of the evaluation will be on understanding the successes of supported technologies and will occur with three respondent groups: IMAT awardees, a sample of awardees from NIH funded programs on technology development beyond the IMAT program, and technology end users. The evaluation approach is to be centered on tracking or following all supported technologies since 1998. To date, the IMAT program has issued 513 R21 and R33 awards and 160 SBIR and STTR awards, supporting roughly 500 unique technology platforms.

---

Authorizing Statute(s): US Code: 42 USC 285 Name of Law: Public Health Service Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	79 FR 72004	12/04/2014
30-day Notice:	Federal Register Citation:	Citation Date:
	80 FR 12487	03/09/2015
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 3

IC Title	Form No.	Form Name
Technology Grantees Web-based Survey	2	IMAT Web Survey
Technology End Users Interview Guide	3	IMAT Technology End User Interview
IMAT Grantee Interview	1	IMAT Interview Guide

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	1,050	0	0	1,050	0	0
Annual Time Burden (Hours)	575	0	0	575	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: new submission

---

Annual Cost to Federal Government: $149,570

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 03/10/2015

---